Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Accurately Determines Breast Cancer Prognosis

By LabMedica International staff writers
Posted on 18 Jul 2025

A new study has found that cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to treatment. More...

The research, published in the journal Patterns, marks a significant step toward developing artificial intelligence (AI) tools to help oncologists more accurately determine prognoses and decide which treatments may be most effective on a case-by-case basis.

Researchers at Johns Hopkins University (Baltimore, MD, USA) have designed an interpretable machine learning model that analyzed images of microscopic tissues and biopsy samples from 579 breast cancer patients who were undergoing standard treatments such as chemotherapy. The model examined both the tumor and the surrounding tissue, assessing every cell’s position in relation to the tumor and interactions with neighboring cells. This allowed the algorithm to detect 66 unique cell patterns and categorize patients into seven prognostic groups based on these patterns. Unlike conventional AI methods, the model could clearly identify which specific elements contributed to each pattern, allowing researchers to reverse-engineer the data and uncover the driving factors behind the groupings.

The model’s validation revealed several significant findings. One group of patients with the best survival outcomes had a distinct combination of three cell types: CK8-18high, CXCL12high, and CK+CXCL12+. On the other hand, patients with self-aggregated HER2+ tumor cells had the worst outcomes—a result that aligns with the known aggressiveness of HER2-positive breast cancers. Additionally, triple-negative breast cancer patients with well-organized immune cells surrounding their tumors also had better prognoses than others with the same condition. These results suggest that analyzing spatial tissue patterns may provide oncologists with valuable biomarkers for predicting patient outcomes and personalizing treatment strategies. Moving forward, the researchers plan to expand their methodology to other imaging technologies and apply it to different types of cancer to uncover more actionable insights.

"We're developing a toolbox that you can use anytime you have a massive data set and you don't want to start with an explicit hypothesis," said first author Zhenzhen Wang, a PhD candidate in biomedical engineering at Johns Hopkins University. "Typically, you'd have to design a study to ask if one specific pattern of cells is important, and check if the answer is yes or no. But with our model, we can save time by asking open-ended questions about which patterns are important when trying to understand how patients will respond to treatment or have a better chance of survival."

Related Links:
Johns Hopkins University


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Portable Electronic Pipette
Mini 96
ESR Analyzer
TEST1 2.0
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: The partnership between OGT and QIAGEN unlocks a complete sample to report workflow for SureSeq NGS panels (Photo courtesy of OGT)

Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation

In clinical research, next-generation sequencing (NGS) panels provide essential insights for genetic analysis, but many laboratories face challenges in transforming raw sequencing data into clinically... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.